Determination of Levofloxacin in Human Gastric Mucosa by HPLC

Xingping HU,Yongmei HU,Lei ZHANG,Lingling LUO,Jianming XU
DOI: https://doi.org/10.16522/j.cnki.cjph.2014.07.005
2014-01-01
Abstract:An HPLC method was established for the determination of levofl oxacin in the human gastric mucosa. Thirty-seven patients with Helicobacter pylori(Hp) infection suffering from chronic gastritis participated in the study. All patients received therapy with 7 days of levofloxacin-based triple regime(esomeprazole 20 mg plus amoxicillin 1 000 mg, twice a day and levofl oxacin 500 mg once a day). They received gastroscopy and were drawn three mucosal tissue from antrum after the end of treatment. The gastric mucosa were homogenized. The concentration of levofl oxacin in gastric mucosa was determined by HPLC. A Hypersil ODS C18 column was used with the mobile phase of acetonitrile︰50 mmol/L citric acid︰1 mol/L ammonium acetate solution(27︰72︰1) at the detection wavelength of 295 nm. It was linear in the range of 0.5- 10 μg/g. The recoveries for levofl oxacin of low, medium and high concentrations were 96.4%, 95.2% and 102.8%. The intra- and inter-day RSDs were 6.70%, 2.01%, 1.46% and 7.40%, 4.56%, 3.62%, respectively. The concentration of levofl oxacin in gastric mucosal were(6.05±2.47)μg/g in these patients.
What problem does this paper attempt to address?